Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 156

1.

Autoantibodies against CD74 in spondyloarthritis.

Baerlecken NT, Nothdorft S, Stummvoll GH, Sieper J, Rudwaleit M, Reuter S, Matthias T, Schmidt RE, Witte T.

Ann Rheum Dis. 2014 Jun;73(6):1211-4. doi: 10.1136/annrheumdis-2012-202208. Epub 2013 May 17.

PMID:
23687263
2.

High prevalence of anti-CD74 antibodies specific for the HLA class II-associated invariant chain peptide (CLIP) in patients with axial spondyloarthritis.

Baraliakos X, Baerlecken N, Witte T, Heldmann F, Braun J.

Ann Rheum Dis. 2014 Jun;73(6):1079-82. doi: 10.1136/annrheumdis-2012-202177. Epub 2013 May 3.

PMID:
23644552
3.

Increased levels of IgG antibodies against human HSP60 in patients with spondyloarthritis.

Hjelholt A, Carlsen T, Deleuran B, Jurik AG, Schiøttz-Christensen B, Christiansen G, Birkelund S.

PLoS One. 2013;8(2):e56210. doi: 10.1371/journal.pone.0056210. Epub 2013 Feb 12.

4.

Cartilage collagen type II seromarker patterns in axial spondyloarthritis and psoriatic arthritis: associations with disease activity, smoking and HLA-B27.

Munk HL, Gudmann NS, Christensen AF, Ejstrup L, Sorensen GL, Loft AG, Bay-Jensen AC, Siebuhr AS, Junker P.

Rheumatol Int. 2016 Apr;36(4):541-9. doi: 10.1007/s00296-015-3397-8. Epub 2015 Nov 30.

PMID:
26620690
5.

Activation-Induced Killer Cell Immunoglobulin-like Receptor 3DL2 Binding to HLA-B27 Licenses Pathogenic T Cell Differentiation in Spondyloarthritis.

Ridley A, Hatano H, Wong-Baeza I, Shaw J, Matthews KK, Al-Mossawi H, Ladell K, Price DA, Bowness P, Kollnberger S.

Arthritis Rheumatol. 2016 Apr;68(4):901-14. doi: 10.1002/art.39515.

6.

Anti-saccharomyces cerevisiae IgA antibodies are raised in ankylosing spondylitis and undifferentiated spondyloarthropathy.

Hoffman IE, Demetter P, Peeters M, De Vos M, Mielants H, Veys EM, De Keyser F.

Ann Rheum Dis. 2003 May;62(5):455-9.

7.

IgG subclass antibodies to human and bacterial HSP60 are not associated with disease activity and progression over time in axial spondyloarthritis.

Carlsen TG, Hjelholt A, Jurik AG, Schiøttz-Christensen B, Zejden A, Christiansen G, Deleuran B, Birkelund S.

Arthritis Res Ther. 2013;15(3):R61.

8.

Effect of enthesitis on 1505 Brazilian patients with spondyloarthritis.

Carneiro S, Bortoluzzo A, Gonçalves C, Silva JA, Ximenes AC, Bértolo M, Ribeiro SL, Keiserman M, Skare T, Menin R, Azevedo V, Vieira W, Albuquerque E, Bianchi W, Bonfiglioli R, Campanholo C, Carvalho HM, Costa Id, Duarte A, Kohem C, Leite N, Lima SA, Meirelles ES, Pereira IA, Pinheiro MM, Polito E, Resende GG, Rocha FA, Santiago MB, Sauma Mde F, Valim V, Sampaio-Barros PD.

J Rheumatol. 2013 Oct;40(10):1719-25. doi: 10.3899/jrheum.121145. Epub 2013 Jul 15.

PMID:
23858049
9.

IgA and IgG autoantibodies against alpha-fodrin as markers for Sjögren's syndrome. Systemic lupus erythematosus.

Witte T, Matthias T, Arnett FC, Peter HH, Hartung K, Sachse C, Wigand R, Braner A, Kalden JR, Lakomek HJ, Schmidt RE.

J Rheumatol. 2000 Nov;27(11):2617-20.

PMID:
11093442
10.

Antibodies to Klebsiella, Proteus, and HLA-B27 peptides in Japanese patients with ankylosing spondylitis and rheumatoid arthritis.

Tani Y, Tiwana H, Hukuda S, Nishioka J, Fielder M, Wilson C, Bansal S, Ebringer A.

J Rheumatol. 1997 Jan;24(1):109-14.

PMID:
9002020
11.

Undifferentiated spondyloarthritis vs ankylosing spondylitis and psoriatic arthritis: a real-life prospective cohort study of clinical presentation and response to treatment.

Paramarta JE, De Rycke L, Ambarus CA, Tak PP, Baeten D.

Rheumatology (Oxford). 2013 Oct;52(10):1873-8. doi: 10.1093/rheumatology/ket239. Epub 2013 Jul 16.

PMID:
23861532
12.

[Spondyloarthritides].

Braun J, Sieper J.

Z Rheumatol. 2010 Jul;69(5):425-32; quiz 433-4. doi: 10.1007/s00393-009-0591-7. Review. German.

PMID:
20490514
13.

Increased IgA antibodies to cytokeratins in the spondyloarthropathies.

Borg AA, Nixon NB, Dawes PT, Mattey DL.

Ann Rheum Dis. 1994 Jun;53(6):391-5.

14.

Relationship of Psoriatic Arthritis to Other Spondyloarthritides.

Olivieri I, D'Angelo S, Gilio M, Palazzi C, Lubrano E, Padula A.

J Rheumatol Suppl. 2015 Nov;93:33-5. doi: 10.3899/jrheum.150632.

PMID:
26523053
15.

An epidemiological survey of low back pain and axial spondyloarthritis in a Chinese Han population.

Liao ZT, Pan YF, Huang JL, Huang F, Chi WJ, Zhang KX, Lin ZM, Wu YQ, He WZ, Wu J, Xie XJ, Huang JX, Wei QJ, Li TW, Wu Z, Yu BY, Gu JR.

Scand J Rheumatol. 2009 Nov-Dec;38(6):455-9. doi: 10.3109/03009740902978085.

PMID:
19922021
16.

Comparison of the antibody responses to the 77 Klebsiella capsular types in ankylosing spondylitis and various rheumatic diseases.

Sahly H, Kekow J, Podschun R, Schaff M, Gross WL, Ullmann U.

Infect Immun. 1994 Nov;62(11):4838-43.

17.

Assessment of SpondyloArthritis International Society criteria for axial spondyloarthritis in chronic back pain patients with a high prevalence of HLA-B27.

Bakland G, Alsing R, Singh K, Nossent JC.

Arthritis Care Res (Hoboken). 2013 Mar;65(3):448-53. doi: 10.1002/acr.21804.

18.

Absence of a classically activated macrophage cytokine signature in peripheral spondylarthritis, including psoriatic arthritis.

Vandooren B, Noordenbos T, Ambarus C, Krausz S, Cantaert T, Yeremenko N, Boumans M, Lutter R, Tak PP, Baeten D.

Arthritis Rheum. 2009 Apr;60(4):966-75. doi: 10.1002/art.24406.

19.

Optimizing the identification of patients with axial spondyloarthritis in primary care--the case for a two-step strategy combining the most relevant clinical items with HLA B27.

Braun A, Gnann H, Saracbasi E, Grifka J, Kiltz U, Letschert K, Braun J.

Rheumatology (Oxford). 2013 Aug;52(8):1418-24. doi: 10.1093/rheumatology/ket115. Epub 2013 Apr 4.

PMID:
23559574
20.

Increased expression of human leucocyte antigen class I free heavy chains on monocytes of patients with spondyloarthritis and cells transfected with HLA-B27.

Ding J, Feng Y, Zheng ZH, Li XY, Wu ZB, Zhu P.

Int J Immunogenet. 2015 Feb;42(1):4-10. doi: 10.1111/iji.12169. Epub 2014 Dec 24.

PMID:
25545293

Supplemental Content

Support Center